
自引率: 2.8%
被引量: 1503
通过率: 暂无数据
审稿周期: 9
版面费用: 暂无数据
国人发稿量: 15
投稿须知/期刊简介:
The Journal of Chemotherapy is an international scholarly journal published bimonthly in Florence, Italy and is published under the auspices of the Italian Society of Chemotherapy and of the Italian Federation of Human and Animal Mycopathology. The Journal of Chemotherapy deals with all aspects of antimicrobial, immunomodulating and anticancer chemotherapy. The Journal of Chemotherapy is committed to the rapid publication of high quality, peer reviewed, original research and review articles, short communications and letters in English. Letters that comment on an article previously published in the Journal of Chemotherapy are also welcomed.
期刊描述简介:
The Journal of Chemotherapy is an international scholarly journal published bimonthly in Florence, Italy and is published under the auspices of the Italian Society of Chemotherapy and of the Italian Federation of Human and Animal Mycopathology. The Journal of Chemotherapy deals with all aspects of antimicrobial, immunomodulating and anticancer chemotherapy. The Journal of Chemotherapy is committed to the rapid publication of high quality, peer reviewed, original research and review articles, short communications and letters in English. Letters that comment on an article previously published in the Journal of Chemotherapy are also welcomed.
-
Intraperitoneal daptomycin dosing for peritonitis may be inadequate: a Monte Carlo simulation approach to optimize dosing and outcomes.
被引量:- 发表:1970
-
Risk factors of poor nutrition in non-small cell lung cancer patients after chemotherapy: cross-sectional study.
被引量:- 发表:1970
-
Effect of postsurgical adjuvant chemotherapy timing on outcomes in patients with pancreatic cancer - a systematic review and meta-analysis.
被引量:- 发表:1970
-
Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma.
被引量:- 发表:1970
-
Efficacy and safety of anlotinib as maintenance therapy in patients with advanced non-small cell lung cancer achieving SD post first-line chemotherapy combined with immunotherapy.
被引量:- 发表:1970